A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Conditions: Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis Intervention: Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | Crohn's Disease | Genetics | Inflammatory Bowel Disease | Learning | Pfizer | Psoriasis | Remicade | Research | Rheumatoid Arthritis | Rheumatology | Study | Ulcerative Colitis | Universities & Medical Training